Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy LeMaitre Vascular stock | $51.21

Learn how to easily invest in LeMaitre Vascular stock.

LeMaitre Vascular, Inc
+$1.00 (+1.84%)

LeMaitre Vascular, Inc is a medical instruments & supplies business based in the US. LeMaitre Vascular shares (LMAT) are listed on the NASDAQ and all prices are listed in US Dollars. LeMaitre Vascular employs 386 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in LeMaitre Vascular

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LMAT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

LeMaitre Vascular stock price (NASDAQ: LMAT)

Use our graph to track the performance of LMAT stocks over time.

LeMaitre Vascular shares at a glance

Information last updated 2021-07-30.
Latest market close$51.21
52-week range$27.63 - $64.50
50-day moving average $58.48
200-day moving average $51.27
Wall St. target price$62.00
PE ratio 47.0603
Dividend yield $0.395 (0.72%)
Earnings per share (TTM) $1.16

Buy LeMaitre Vascular shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy LeMaitre Vascular stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

LeMaitre Vascular price performance over time

Historical closes compared with the close of $51.21 from 2021-05-28

1 week (2021-07-22) N/A
1 month (2021-07-02) -14.28%
3 months (2021-04-30) -2.40%
6 months (2021-01-29) N/A
1 year (2020-07-29) N/A
2 years (2019-07-29) N/A
3 years (2018-07-29) N/A
5 years (2016-07-29) N/A

Is LeMaitre Vascular under- or over-valued?

Valuing LeMaitre Vascular stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LeMaitre Vascular's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LeMaitre Vascular's P/E ratio

LeMaitre Vascular's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, LeMaitre Vascular shares trade at around 47x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

LeMaitre Vascular's PEG ratio

LeMaitre Vascular's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.2305. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LeMaitre Vascular's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

LeMaitre Vascular's EBITDA

LeMaitre Vascular's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $41.4 million.

The EBITDA is a measure of a LeMaitre Vascular's overall financial performance and is widely used to measure a its profitability.

LeMaitre Vascular financials

Revenue TTM $134.7 million
Operating margin TTM 23.69%
Gross profit TTM $84.6 million
Return on assets TTM 9.24%
Return on equity TTM 14.69%
Profit margin 17.8%
Book value $8.62
Market capitalisation $1.2 billion

TTM: trailing 12 months

Shorting LeMaitre Vascular shares

There are currently 1.3 million LeMaitre Vascular shares held short by investors – that's known as LeMaitre Vascular's "short interest". This figure is 2.4% up from 1.2 million last month.

There are a few different ways that this level of interest in shorting LeMaitre Vascular shares can be evaluated.

LeMaitre Vascular's "short interest ratio" (SIR)

LeMaitre Vascular's "short interest ratio" (SIR) is the quantity of LeMaitre Vascular shares currently shorted divided by the average quantity of LeMaitre Vascular shares traded daily (recently around 208399.18300654). LeMaitre Vascular's SIR currently stands at 6.12. In other words for every 100,000 LeMaitre Vascular shares traded daily on the market, roughly 6120 shares are currently held short.

However LeMaitre Vascular's short interest can also be evaluated against the total number of LeMaitre Vascular shares, or, against the total number of tradable LeMaitre Vascular shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case LeMaitre Vascular's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 LeMaitre Vascular shares in existence, roughly 60 shares are currently held short) or 0.0703% of the tradable shares (for every 100,000 tradable LeMaitre Vascular shares, roughly 70 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against LeMaitre Vascular.

Find out more about how you can short LeMaitre Vascular stock.

LeMaitre Vascular share dividends


Dividend payout ratio: 41.41% of net profits

Recently LeMaitre Vascular has paid out, on average, around 41.41% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.8% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), LeMaitre Vascular shareholders could enjoy a 0.8% return on their shares, in the form of dividend payments. In LeMaitre Vascular's case, that would currently equate to about $0.395 per share.

While LeMaitre Vascular's payout ratio might seem fairly standard, it's worth remembering that LeMaitre Vascular may be investing much of the rest of its net profits in future growth.

LeMaitre Vascular's most recent dividend payout was on 2 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 17 May 2021 (the "ex-dividend date").

LeMaitre Vascular share price volatility

Over the last 12 months, LeMaitre Vascular's shares have ranged in value from as little as $27.6279 up to $64.495. A popular way to gauge a stock's volatility is its "beta".

LMAT.US volatility(beta: 1.36)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LeMaitre Vascular's is 1.358. This would suggest that LeMaitre Vascular's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

LeMaitre Vascular overview

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors.

Frequently asked questions

What percentage of LeMaitre Vascular is owned by insiders or institutions?
Currently 12.027% of LeMaitre Vascular shares are held by insiders and 85.546% by institutions.
How many people work for LeMaitre Vascular?
Latest data suggests 386 work at LeMaitre Vascular.
When does the fiscal year end for LeMaitre Vascular?
LeMaitre Vascular's fiscal year ends in December.
Where is LeMaitre Vascular based?
LeMaitre Vascular's address is: 63 Second Avenue, Burlington, MA, United States, 01803
What is LeMaitre Vascular's ISIN number?
LeMaitre Vascular's international securities identification number is: US5255582018
What is LeMaitre Vascular's CUSIP number?
LeMaitre Vascular's Committee on Uniform Securities Identification Procedures number is: 525558201

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site